Epidemiology Practice Questions

Q: What is the incubation period of Hepatitis B?

50-160 days. **Explanation:** The incubation period of a disease is the interval between the entry of the pathogen and the appearance of the first clinical sign or symptom. For **Hepatitis B Virus (HBV)**, the incubation period is characteristically long and variable, typically ranging from **30 to 180 days**, with an average of **50–160 days**. * **Why Option B is Correct:** According to standard epidemiological textbooks (like Park’s PSM), Hepatitis B is known as "long-incubation hepatitis." The 50-160 day window reflects the slow replication cycle of the DNA virus and the time required for the host's immune response to trigger clinical symptoms. * **Why Option A is Incorrect:** 15–50 days (average 28-30 days) is the incubation period for **Hepatitis A and Hepatitis E**. These are transmitted via the fecal-oral route and have a much shorter clinical onset. * **Why Option C & D are Incorrect:** 10 days is too short for any viral hepatitis. While 100 days falls within the range of Hepatitis B, it is a single point in time rather than the established epidemiological range (50-160 days) used for classification. **High-Yield Clinical Pearls for NEET-PG:** * **Hepatitis B:** DNA virus (Hepadnaviridae); incubation 50–160 days. * **Hepatitis C:** Incubation period is **30–120 days** (Average 6-7 weeks). * **Rule of Thumb:** Hepatitis A and E (Fecal-oral) are "Short Incubation," while B, C, and D (Parenteral) are "Long Incubation." * **HBsAg:** The first serological marker to appear in blood after infection (even before symptoms).

Q: A country with a zero population growth rate is in which stage of the demographic cycle?

Fourth. **Explanation:** The **Demographic Cycle** describes the historical shift in birth and death rates as a country develops. The correct answer is **Stage 4 (Low Stationary)** because this is the phase where the birth rate declines to match the already low death rate, resulting in a **Zero Population Growth (ZPG)** rate. **Breakdown of Stages:** * **Stage 1 (High Stationary):** Characterized by high birth and high death rates. The population remains stable but at a low level. * **Stage 2 (Early Expanding):** Death rates begin to fall due to improved healthcare and sanitation, while birth rates remain high. This leads to the "population explosion." * **Stage 3 (Late Expanding):** Death rates continue to fall, and birth rates finally begin to decline. The population still grows, but at a slower pace. * **Stage 4 (Low Stationary):** Both birth and death rates are low and equal. This is where **Zero Population Growth** occurs (e.g., many European countries). * **Stage 5 (Declining):** Birth rates fall below death rates, leading to a negative growth rate and a shrinking population (e.g., Germany, Japan). **High-Yield NEET-PG Pearls:** * **India's Status:** Currently, India is in **Late Stage 3** of the demographic cycle. * **Net Reproduction Rate (NRR):** For a country to achieve ZPG, the NRR must be **1**. * **Total Fertility Rate (TFR):** The replacement level fertility required for ZPG is approximately **2.1**. * **Key Indicator:** The transition from Stage 2 to Stage 3 is primarily driven by a decline in the birth rate.

Q: Herd immunity is not useful in which of the following diseases?

Tetanus. **Explanation** The correct answer is **Tetanus**. **1. Why Tetanus is the correct answer:** Herd immunity (community immunity) occurs when a large portion of a population becomes immune to an infectious disease, thereby reducing the likelihood of person-to-person transmission. For herd immunity to be effective, the disease must be **communicable** (spread from one individual to another). Tetanus is caused by *Clostridium tetani* spores found in the soil. It is **non-communicable**; an infected person cannot transmit the disease to others. Therefore, vaccinating 99% of a population does not protect the remaining 1% from environmental exposure. Protection against tetanus is strictly individual. **2. Why the other options are incorrect:** * **Diphtheria, Polio, and Measles** are all highly communicable diseases spread via respiratory droplets or the feco-oral route. * In these cases, when a critical threshold of the population is immune (via vaccination or natural infection), the chain of transmission is broken, protecting unvaccinated or immunocompromised individuals in the community. **3. High-Yield Clinical Pearls for NEET-PG:** * **Herd Immunity Threshold:** The proportion of immune individuals required to stop transmission. It is calculated as $1 - (1/R_0)$. * **Measles:** Requires the highest herd immunity threshold (approx. 94–95%) due to its high basic reproduction number ($R_0$). * **Prerequisites for Herd Immunity:** 1. The agent must be restricted to a single host species (humans). 2. Transmission must be direct (person-to-person). 3. Infection must induce solid, long-lasting immunity. * **Tetanus** is the classic exception used in exams to test the understanding that herd immunity does not apply to environmental/non-communicable pathogens.

Q: Influenza pandemics typically show which type of epidemiological trend?

Cyclical. ### Explanation **Correct Answer: B. Cyclical** **Why Cyclical is correct:** In epidemiology, a **cyclical trend** refers to the occurrence of a disease in periodic waves or cycles spanning several years. Influenza pandemics are the classic example of this trend. They occur at irregular intervals (typically every 10–40 years) due to **Antigenic Shift**. This major genetic change results in a completely new subtype of the Hemagglutinin or Neuraminidase proteins, to which the global population has no immunity, leading to a worldwide pandemic. **Why other options are incorrect:** * **A. Secular:** This refers to long-term changes (decades or centuries) in the occurrence of a disease, such as the gradual decline of Tuberculosis or the rise of lifestyle diseases like Diabetes. While pandemics happen over decades, the "wave-like" recurrence makes them cyclical. * **C. Seasonal:** This refers to fluctuations within a single year based on environmental factors. While **seasonal influenza** (epidemics) occurs every winter in temperate climates due to **Antigenic Drift**, the question specifically asks for **pandemics**, which follow a multi-year cyclical pattern. **NEET-PG High-Yield Pearls:** * **Antigenic Shift:** Major change $\rightarrow$ New subtype $\rightarrow$ **Pandemic** (Cyclical trend). * **Antigenic Drift:** Minor change (point mutations) $\rightarrow$ Same subtype $\rightarrow$ **Epidemic** (Seasonal trend). * **Other Cyclical Examples:** Measles (pre-vaccination era, every 2–3 years) and Rubella (every 6–9 years). * **Secular Trend Example:** The steady increase in Coronary Heart Disease over the last 50 years.

Q: Which of the following types of bias can be reduced by allowing equal interview time?

Interviewer bias. ### Explanation **Interviewer Bias** occurs when the investigator’s preconceived notions or systematic differences in the way data is collected influence the results. This often happens when an interviewer spends more time, asks more probing questions, or provides more cues to the "cases" compared to the "controls." By **standardizing the interview process**—such as allowing equal interview time and using structured questionnaires—the investigator ensures that both groups are treated identically, thereby minimizing this bias. #### Analysis of Incorrect Options: * **Berksonian Bias (Admission Rate Bias):** This is a type of selection bias that occurs in hospital-based case-control studies because the combination of two diseases increases the likelihood of hospital admission. It is related to the study setting/sampling, not the interview process. * **Recall Bias:** This occurs when cases (diseased individuals) remember past exposures more clearly or differently than controls. It is a limitation of the respondent's memory, not the interviewer's behavior. It is best reduced by using objective records or blinding the participants. * **Selection Bias:** This refers to systematic errors in the process of identifying the study populations (e.g., non-response bias or volunteer bias). It occurs at the recruitment stage, whereas interviewer bias occurs during the data collection stage. #### NEET-PG High-Yield Pearls: * **Blinding:** The most effective way to eliminate interviewer bias is to keep the interviewer "blind" to the hypothesis or the case/control status of the participant. * **Hawthorne Effect:** A type of bias where study participants change their behavior because they know they are being watched. * **Lead-time Bias:** Often confused with epidemiology biases, this is specific to screening programs where early diagnosis makes it appear as though survival has increased, even if the course of the disease is unchanged.

Q: Which of the following is an example of multipurpose screening?

Annual health check-ups. **Explanation:** **Screening** is the process of identifying unrecognized diseases in apparently healthy individuals using rapidly applied tests. Screening is classified into different types based on the objective and the population covered. **Why Option B is Correct:** **Multipurpose (or Multiphasic) Screening** refers to the application of two or more screening tests to a large population at the same time to detect several diseases simultaneously, rather than focusing on a single disease. **Annual health check-ups** are the classic example because they involve a battery of tests (e.g., blood pressure, blood glucose, lipid profile, and BMI) to screen for multiple non-communicable diseases (NCDs) like hypertension, diabetes, and obesity in one visit. **Analysis of Incorrect Options:** * **Option A (Chest X-ray for TB):** This is an example of **Mass Screening**, where a single screening test is applied to the whole population (or a large subgroup) regardless of the risk level. * **Option C (Pap smear in elderly):** This is an example of **Selective (High-risk) Screening**. It targets a specific group known to be at higher risk for a particular condition (Cervical Cancer). * **Option D (Eye check-up in school children):** This is also a form of **Mass/Selective Screening** targeting a specific age group for a single morbidity (refractive errors). **High-Yield NEET-PG Pearls:** * **Opportunistic Screening:** When a patient visits a doctor for one complaint (e.g., a cold) and the doctor screens them for another (e.g., checking BP). * **Lead Time:** The period between early detection by screening and the time of usual clinical diagnosis. * **Iceberg Phenomenon:** Screening is primarily aimed at the "submerged portion" of the iceberg (latent, undiagnosed, or asymptomatic cases).

Q: Which of the following statements about incidence is true?

Incidence is not affected by the duration of the disease.. **Explanation:** **1. Why Option A is Correct:** Incidence is defined as the number of **new cases** occurring in a defined population during a specific period. It is a measure of the **rate** at which a disease develops. Because incidence only counts the event of "becoming ill," it is independent of how long the patient remains ill. Whether a disease lasts 2 days or 20 years, it is counted as exactly one incident case at the time of onset. **2. Why the Other Options are Incorrect:** * **Option B:** Incidence is not always more than prevalence. In chronic diseases (like Diabetes), prevalence is usually much higher than incidence because cases accumulate over time. * **Option C:** Incidence measures **only new cases**. Prevalence is the measure that combines both old and new cases ($P = I \times D$). * **Option D:** Incidence is primarily used for **acute conditions** (e.g., influenza, outbreaks) to study etiology and causation. Prevalence is the preferred measure for chronic conditions to assess the burden on the healthcare system. **3. High-Yield Clinical Pearls for NEET-PG:** * **The Formula:** $Prevalence (P) = Incidence (I) \times Mean\ Duration\ of\ disease (D)$. * **Denominator:** The denominator for Incidence is "Population at Risk," whereas for Prevalence, it is the "Total Population" (at risk + already diseased). * **Attack Rate:** This is a type of incidence rate used specifically during short-term outbreaks. * **Rule of Thumb:** If a new treatment is discovered that cures a disease quickly (decreasing duration), the **Prevalence will decrease**, but the **Incidence will remain unchanged**.

Q: When a drug is evaluated for its usefulness in controlled conditions, what does this signify?

Efficacy. ### Explanation In Biostatistics and Epidemiology, the evaluation of a drug or intervention is categorized based on the environment in which the study is conducted. **1. Why Efficacy is Correct:** **Efficacy** refers to the performance of an intervention under **ideal and controlled conditions** (e.g., a Randomized Controlled Trial). It answers the question: *"Can the drug work?"* In these settings, factors like patient compliance, co-morbidities, and environmental variables are strictly monitored to isolate the drug's direct biological effect. **2. Analysis of Incorrect Options:** * **Effectiveness:** This refers to how well a drug performs in **real-world clinical settings** (routine practice). It accounts for factors like poor patient compliance, provider error, and diverse patient populations. It answers: *"Does the drug work in practice?"* * **Efficiency:** This measures the results achieved in relation to the **resources consumed** (money, time, manpower). It is essentially a cost-benefit or cost-effectiveness analysis. It answers: *"Is it worth the cost?"* * **Effect Modification:** This is a biological phenomenon where the magnitude of an effect of an exposure on an outcome varies according to the level of a third variable (the modifier). It is not a measure of drug usefulness. **3. NEET-PG High-Yield Pearls:** * **Phase II & III Clinical Trials** primarily measure **Efficacy**. * **Phase IV (Post-marketing surveillance)** primarily measures **Effectiveness**. * **Mnemonic (The 3 E’s):** * **Efficacy:** **I**deal conditions (**I** in Efficacy). * **Effectiveness:** **R**eal world (**R** in Effectiveness). * **Efficiency:** **M**oney/Resources (**M** in Efficiency). * **Intention-to-treat (ITT) analysis** is used to preserve the benefits of randomization and is often used to estimate effectiveness.

Question 1

What is the best level of prevention for Breast cancer?

Accepted Answer

Early diagnosis and treatment

Answer

Specific protection

Answer

Disability limitation

Answer

Rehabilitation

Question 2

Follow-up of cataract operations in the national blindness control program is done by which method?

Accepted Answer

Sentinel surveillance

Answer

Active surveillance

Answer

Passive surveillance

Answer

Routine check-up

Question 3

What is the incubation period of Hepatitis B?

Accepted Answer

50-160 days

Answer

15-50 days

Answer

10 days

Answer

100 days

Question 4

A country with a zero population growth rate is in which stage of the demographic cycle?

Accepted Answer

Fourth

Answer

First

Answer

Second

Answer

Third

Question 5

Herd immunity is not useful in which of the following diseases?

Accepted Answer

Tetanus

Answer

Diphtheria

Answer

Polio

Answer

Measles

Question 6

Influenza pandemics typically show which type of epidemiological trend?

Accepted Answer

Cyclical

Answer

Secular

Answer

Seasonal

Answer

None of the above

Question 7

Which of the following types of bias can be reduced by allowing equal interview time?

Accepted Answer

Interviewer bias

Answer

Berksonian bias

Answer

Recall bias

Answer

Selection bias

Question 8

Which of the following is an example of multipurpose screening?

Accepted Answer

Annual health check-ups

Answer

Chest X-ray for tuberculosis in a large population

Answer

Pap smear in elderly females

Answer

Eye check-up in school children

Question 9

Which of the following statements about incidence is true?

Accepted Answer

Incidence is not affected by the duration of the disease.

Answer

Incidence is always more than prevalence.

Answer

Incidence measures both old and new cases.

Answer

Incidence is primarily used for chronic conditions.

Question 10

When a drug is evaluated for its usefulness in controlled conditions, what does this signify?

Accepted Answer

Efficacy

Answer

Effectiveness

Answer

Efficiency

Answer

Effect modification

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?